Literature DB >> 19269347

In vivo assessment of hepatic triglycerides in murine non-alcoholic fatty liver disease using magnetic resonance spectroscopy.

Ian R Corbin1, Emma E Furth, Stephen Pickup, Evan S Siegelman, Edward J Delikatny.   

Abstract

In vivo(1)H magnetic resonance spectroscopy (MRS) was used to examine the progression of fatty liver in two murine models of progressive hepatic steatosis: leptin-deficient obese (ob/ob) mice and mice maintained on a diet deficient in methionine and choline (MCDD). Ob/ob mice displayed high levels of intracellular hepatic triglycerides as early as 9 weeks after birth, as observed with MRS and histopathology. Single voxel spectra of ob/ob liver displayed strong resonances arising from saturated (1.3 ppm) and unsaturated (2.8 and 5.3 ppm) fatty acyl chains that could be resolved in the absence of water suppression. Hepatic inflammation, induced by lipopolysaccharide administration, led to a significant increase in unsaturated and polyunsaturated fatty acyl chain resonances (P<0.05), indicating a change in the composition of hepatic triglycerides in lipid droplets. Mice maintained on the MCDD displayed histological evidence of hepatic steatosis as early as two weeks, progressing to macrovesicular steatohepatitis at 10 weeks. The histological changes were accompanied by significant increases in saturated and unsaturated fatty acyl chain resonances and a significant decrease in the lipid/(water+lipid) ratio (P<0.05). These results indicate that in vivo(1)H MRS may be a suitable method to monitor the progression of steatohepatitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19269347     DOI: 10.1016/j.bbalip.2009.02.014

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  16 in total

1.  The effect of water suppression on the hepatic lipid quantification, as assessed by the LCModel, in a preclinical and clinical scenario.

Authors:  Amandine Coum; Fanny Noury; Elise Bannier; Karima Begriche; Bernard Fromenty; Yves Gandon; Hervé Saint-Jalmes; Giulio Gambarota
Journal:  MAGMA       Date:  2015-11-21       Impact factor: 2.310

2.  Label-free imaging and analysis of the effects of lipolysis products on primary hepatocytes.

Authors:  Iwan W Schie; Jian Wu; Tyler Weeks; Mark A Zern; John C Rutledge; Thomas Huser
Journal:  J Biophotonics       Date:  2010-09-28       Impact factor: 3.207

3.  Hepatic lipid composition differs between ob/ob and ob/+ control mice as determined by using in vivo localized proton magnetic resonance spectroscopy.

Authors:  Qiong Ye; Carsten Friedrich Danzer; Alexander Fuchs; Christian Wolfrum; Markus Rudin
Journal:  MAGMA       Date:  2012-03-23       Impact factor: 2.310

4.  Evaluation of Nonalcoholic Fatty Liver Disease in C57BL/6J Mice by Using MRI and Histopathologic Analyses.

Authors:  Jae-Eun Ryu; Woori Jo; Hyun-Ji Choi; Sungwoong Jang; Hyo-Ju Lee; Dong-Cheul Woo; Jeong Kon Kim; Kyung Won Kim; Eun Sil Yu; Woo-Chan Son
Journal:  Comp Med       Date:  2015-10       Impact factor: 0.982

5.  Gestational and lactational exposure to dichlorinated bisphenol A induces early alterations of hepatic lipid composition in mice.

Authors:  Dounia El Hamrani; Amandine Chepied; William Même; Marc Mesnil; Norah Defamie; Sandra Même
Journal:  MAGMA       Date:  2018-02-20       Impact factor: 2.310

6.  Lipid-cell interactions in human monocytes investigated by doubly-resonant coherent anti-Stokes Raman scattering microscopy.

Authors:  Tyler Weeks; Iwan Schie; Laura J den Hartigh; John C Rutledge; Thomas Huser
Journal:  J Biomed Opt       Date:  2011-02       Impact factor: 3.170

Review 7.  MR-visible lipids and the tumor microenvironment.

Authors:  E James Delikatny; Sanjeev Chawla; Daniel-Joseph Leung; Harish Poptani
Journal:  NMR Biomed       Date:  2011-04-27       Impact factor: 4.044

8.  In vivo hepatic lipid quantification using MRS at 7 Tesla in a mouse model of glycogen storage disease type 1a.

Authors:  Nirilanto Ramamonjisoa; Helene Ratiney; Elodie Mutel; Herve Guillou; Gilles Mithieux; Frank Pilleul; Fabienne Rajas; Olivier Beuf; Sophie Cavassila
Journal:  J Lipid Res       Date:  2013-04-17       Impact factor: 5.922

9.  Hepatic glucagon action is essential for exercise-induced reversal of mouse fatty liver.

Authors:  Eric D Berglund; Daniel G Lustig; Richard A Baheza; Clinton M Hasenour; Robert S Lee-Young; E Patrick Donahue; Sara E Lynes; Larry L Swift; Maureen J Charron; Bruce M Damon; David H Wasserman
Journal:  Diabetes       Date:  2011-09-01       Impact factor: 9.461

10.  Mapping of fatty acid composition with free-breathing MR spectroscopic imaging and compressed sensing.

Authors:  James A Rioux; Miriam Hewlett; Christa Davis; Chris V Bowen; Kimberly Brewer; Sharon E Clarke; Steven D Beyea
Journal:  NMR Biomed       Date:  2020-01-03       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.